
November 7, 2017 - By Winifred Garcia
St James Investment Company Llc decreased its stake in Sanofi (SNY) by 4.6% based on its latest 2017Q2 regulatory filing with the SEC. St James Investment Company Llc sold 67,986 shares as the company’s stock rose 14.25% with the market. The institutional investor held 1.41M shares of the major pharmaceuticals company at the end of 2017Q2, valued at $67.55 million, down from 1.48M at the end of the previous reported quarter. St James Investment Company Llc who had been investing in Sanofi for a number of months, seems to be less bullish one the $115.30 billion market cap company. The stock declined 1.15% or $0.53 reaching $45.52 per share. About 159,652 shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 26.96% since November 7, 2016 and is uptrending. It has outperformed by 10.26% the S&P500.St James Investment Company Llc, which manages about $1.41 billion and $809.19M US Long portfolio, upped its stake in Cvs Health Corp (NYSE:CVS) by 49,242 shares to 870,302 shares, valued at $70.02 million in 2017Q2, according to the filing. More recent Sanofi SA (ADR) (NYSE:SNY) news were published by: Investorplace.com which released: “5 Reasons Why Sanofi SA (ADR) (SNY) is a Good Stock to Buy Now” on April 12, 2017. Also Investorplace.com published the news titled: “Think Sanofi SA (ADR) (SNY) Stock When You Think Big Pharma” on December 09, 2016. Benzinga.com‘s news article titled: “The Pullback In Sanofi Is A Buying Opportunity, Says Argus” with publication date: September 01, 2017 was also an interesting one.Among 11 analysts covering Sanofi-aventis Sa (NYSE:SNY), 3 have Buy rating, 0 Sell and 8 Hold. Therefore 27% are positive. Sanofi-aventis Sa has $56 highest and $50.0 lowest target. $52.67’s average target is 15.71% above currents $45.52 stock price. Sanofi-aventis Sa had 19 analyst reports since October 15, 2015 according to SRatingsIntel. The company was downgraded on Tuesday, May 3 by HSBC. Piper Jaffray initiated the shares of SNY in report on Friday, September 23 with “Neutral” rating. The stock of Sanofi SA (ADR) (NYSE:SNY) earned “Neutral” rating by Goldman Sachs on Monday, November 7. As per Wednesday, August 30, the company rating was upgraded by HSBC. The stock of Sanofi SA (ADR) (NYSE:SNY) earned “Sell” rating by JP Morgan on Friday, March 31. The stock of Sanofi SA (ADR) (NYSE:SNY) has “Hold” rating given on Friday, October 13 by Cowen & Co. The firm has “Reduce” rating given on Friday, April 7 by HSBC. Argus Research initiated the shares of SNY in report on Thursday, April 6 with “Buy” rating. The stock of Sanofi SA (ADR) (NYSE:SNY) has “Hold” rating given on Thursday, May 11 by Berenberg. Bernstein downgraded Sanofi SA (ADR) (NYSE:SNY) on Monday, November 9 to “Mkt Perform” rating.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



(adsbygoogle = window.adsbygoogle || []).push({});
TRADE IDEAS REVIEW – IS THIS THE BEST STOCK SCANNER?

Trade Ideas is arguably one of the top scanning tools available on the market right

Trade Ideas Pro helps traders find the best setups in the market right NOW

Scottrade and E*TRADE license Trade Ideas proprietary technology for their premium trading platforms. We have fully automated trading available through Lightspeed and Interactive Brokers.Trade Ideas is the BEST Tool for Scanning. I would be LOST without Trade ideas. Ross Cameron – Warrior Trading